AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization
Authors
Keywords
Ocular neovascularization, Gene therapy, AAV, Calreticulin anti-angiogenic domain, Diabetic retinopathy, Neovascular age-related macular degeneration
Journal
ANGIOGENESIS
Volume 21, Issue 1, Pages 95-109
Publisher
Springer Nature
Online
2018-01-10
DOI
10.1007/s10456-017-9591-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Delivery of Calreticulin Anti-Angiogenic Domain Attenuates the Development of Choroidal Neovascularization in Rats
- (2017) Youn-Shen Bee et al. HUMAN GENE THERAPY
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Improved Intravitreal AAV-Mediated Inner Retinal Gene Transduction after Surgical Internal Limiting Membrane Peeling in Cynomolgus Monkeys
- (2017) Kazuhisa Takahashi et al. MOLECULAR THERAPY
- The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD
- (2017) Sayantan Datta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Advances in Gene Therapy for Diseases of the Eye
- (2016) Lolita Petit et al. HUMAN GENE THERAPY
- Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
- (2016) Robert L. Avery et al. JAMA Ophthalmology
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2015) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety
- (2015) Guei-Sheung Liu et al. PLoS One
- Sildenafil alters retinal function in mouse carriers of Retinitis Pigmentosa
- (2014) Lisa Nivison-Smith et al. EXPERIMENTAL EYE RESEARCH
- A review of anti-VEGF agents for proliferative diabetic retinopathy
- (2014) P Osaadon et al. EYE
- Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
- (2014) Robert E MacLaren et al. LANCET
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
- (2013) D. Dalkara et al. Science Translational Medicine
- Preferred therapies for neovascular age-related macular degeneration
- (2012) David R. Lally et al. CURRENT OPINION IN OPHTHALMOLOGY
- Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
- (2012) Devy Deliyanti et al. HYPERTENSION
- Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex
- (2012) Imran Bhutto et al. MOLECULAR ASPECTS OF MEDICINE
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
- (2011) C-M Lai et al. GENE THERAPY
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Inflammation in diabetic retinopathy
- (2011) Johnny Tang et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
- (2010) Lesley H. Curtis ARCHIVES OF OPHTHALMOLOGY
- Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse
- (2010) Fansheng Kong et al. EXPERIMENTAL EYE RESEARCH
- Systemic Pro-opiomelanocortin Expression Induces Melanogenic Differentiation and Inhibits Tumor Angiogenesis in Established Mouse Melanoma
- (2010) Guei-Sheung Liu et al. HUMAN GENE THERAPY
- Proliferative retinopathies: Angiogenesis that blinds
- (2009) Przemyslaw Sapieha et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
- (2009) Kip M Connor et al. Nature Protocols
- Self-complementary AAV Vectors; Advances and Applications
- (2008) Douglas M McCarty MOLECULAR THERAPY
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
- (2008) Michael S. Ip et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started